The COVID-19 pandemic has created numerous challenges with the management of lung cancer, not the least of which is the initial diagnosis. The computer tomography scans, typically used in the diagnostic workup, can be obfuscated by the COVID-19 radiologic features therefore this webinar will discuss the best practices on how to distinguish the two. Bronchoscopic and other invasive diagnostic procedures can potentially spread SARS-CoV-2 so there will be a presentation on the precautions that need to be taken in order to reduce exposure risk during these procedures. Once tissue is obtained it needs to be safely handled prior to fixation and then processed for histologic and molecular evaluation, the third topic of the webinar. Finally, an infection disease expert will give an update on COVID-19 and present the implications on SARS-CoV-2 testing in lung cancer patients.
- Are Radiological Features of COVID-19 Distinguishable From Common Thoracic Pathologies? - Edward Patz, MD
- Diagnostic Procedures and Precautions - Joachim Aerts, MD, PhD
- Tissue Handling and Molecular Diagnostics - Lynette Sholl, MD
- Updates on Sequelae of COVID-19 and How to Interpret Testing Results - Paul Antharajah Tambyah, MD
Format: Sequential presentations by the faculty followed by discussion and questions/answers.